<DOC>
	<DOCNO>NCT02737982</DOCNO>
	<brief_summary>The application sex-gender medicine strongly recommend World Health Organization international organization . In fact , emerge , although men woman affect cardiovascular disease ( CVD ) , however different risk factor , disease progression response pharmacological not-pharmacological treatment . Consequentially , identification biomarkers therapeutic approach take account sex gender difference ( SGD ) relevant develop really evidence-based medicine . With aim translate clinical setting recently available basic research evidence estrogens androgen balance involvement modulation ischemia-reperfusion myocardial damage , investigator plan conduct research study patient , affect suspect known ischemic heart disease ( IHD ) undergo angiography and/or percutaneous coronary intervention ( PCI ) , age 18 year sex ratio 1:1 . Thus , set , goal proposal : 1 . To assess sex-gender difference entity microvascular reperfusion damage patient IHD undergoing urgent elective PCI ; 2 . To evaluate estrogen/androgen-dependent -independent effect gender-related difference myocardial ischemia reperfusion damage occur PCI ; 3 . To investigate difference term platelet biology men woman affect IHD undergoing urgent elective PCI , match age clinical cardiovascular metabolic characteristic ; 4 . To verify sex-driven interplay response PCI procedure , platelet function , sex hormone entity reperfusion myocardial damage , well , impact clinical outcome 1-year follow . This research study want explore consequently elucidate biological mechanism responsible sex-based difference vivo human model ischemia reperfusion myocardial damage . Moreover , investigator expect clarify impact biological variable evaluate clinical outcome reperfusion therapeutic intervention .</brief_summary>
	<brief_title>Sex Gender Differences Ischemic Heart Disease - Endocrine Vascular Disease Approach</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>patient ischemic heart disease ( acute chronic ) undergo percutaneous coronary intervention ( urgent elective ) write informed consent sex age 18 year patient expectancy life le 12 month active cancer pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>coronary heart disease</keyword>
	<keyword>gender</keyword>
	<keyword>platelet</keyword>
	<keyword>microvascular dysfunction</keyword>
	<keyword>sexual hormone</keyword>
	<keyword>cardiac magnetic resonance</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>